Listar por autor "Lastra, Enrique"

Mostrando ítems 1-9 de 9

A comprehensive custom panel evaluation for routine hereditary cancer testing: improving the yield of germline mutation detection

Velázquez Pérez, Carolina; Lastra, Enrique; Avila Cobos, Francisco; Abella, Luis; de la Cruz, Virginia; Hernando, Blanca Ascensión; Hernández Sanz, Lara; Martínez Martín, Noemí; Infante Sanz, María Del Mar ; Duran Dominguez, María Mercedes (2020)
A PALB2 truncating mutation: Implication in cancer prevention and therapy of Hereditary Breast and Ovarian Cancer

Velázquez Pérez, Carolina; Esteban Cardeñosa, Eva; Lastra, Enrique; Abella, Luis E.; de la Cruz, Virginia; Domínguez Lobatón, María Carmen ; Duran Dominguez, María Mercedes ; Infante Sanz, María Del Mar (2019)
Application of liquid biopsies in metastatic gastrointestinal cancer to identify candidate therapeutic targets

Perez, Laura; Saiz López, P.; Sánchez Escribano, R.; Rodrigo, A.; García González, M.; Duran Dominguez, María Mercedes ; Infante Sanz, María Del Mar ; Terradez, A.; Faull, I.; Lastra, Enrique (2018)
Evaluating the Effect of Unclassified Variants Identified in MMR Genes Using Phenotypic Features, Bioinformatics Prediction, and RNA Assays

Pérez-Cabornero, Lucia; Infante Sanz, María Del Mar ; Velasco, Eladio; Lastra, Enrique; Miner, Cristina; Duran Dominguez, María Mercedes (2013-05)
Increased co-occurrence of pathogenic variants in hereditary breast and ovarian cancer and Lynch syndromes: A consequence of multigene panel genetic testing?

Infante Sanz, María Del Mar ; Arranz Ledo, Mónica ; Lastra, Enrique; Abella, Luis Enrique; Ferreira, Raquel; Orozco, Marta; Hernández, Lara; Martínez Martín, Noemí; Duran Dominguez, María Mercedes (2022)
Multigene germline testing usefulness instead of BRCA1/2 single screening in triple negative breast cancer cases

Arranz Ledo, Mónica ; Lastra, Enrique; Abella, Luis Enrique; Ferreira, Raquel; Orozco, Marta; Hernández, Lara; Martínez Martín, Noemí; Infante Sanz, María Del Mar ; Duran Dominguez, María Mercedes (2023)
Profiling of the genetic features of patients with breast, ovarian, colorectal and extracolonic cancers: Association to CHEK2 and PALB2 germline mutations

Infante Sanz, María Del Mar ; Arranz Ledo, Mónica ; Lastra, Enrique; Olaverri, Amaya; Ferreira, Raquel; Orozco, Marta; Hernández Sanz, Lara; Martínez Martín, Noemí; Duran Dominguez, María Mercedes (2024)
The highly prevalent BRCA2 mutation c.2808_2811del (3036delACAA) is located in a mutational hotspot and has multiple origins

Infante Sanz, María Del Mar ; Duran Dominguez, María Mercedes ; Acedo, Alberto; Sánchez Tapia, Eva María; Díez Gómez, Beatríz; Barroso, Alicia; García González, María; Feliubadalo, L.; Lasa, Adriana; Hoya, Miguel de la; Esteban Cardeñosa, Eva; Diez, Orland; Martinez Bouzas, Cristina; Godino, Javier; Teulé, Alexandra; Osorio, Ana; Lastra, Enrique; González Sarmiento, Rogelio; Miner, Cristina; Velasco, Eladio A. (2013)
Unraveling the molecular effect of a rare missense mutation in BRIP1 associated with inherited breast cancer

Velázquez Pérez, Carolina; Esteban Cardeñosa, Eva; Lastra, Enrique; Abella, Luis E.; de la Cruz, Virginia; Domínguez Lobatón, María Carmen ; Duran Dominguez, María Mercedes ; Infante Sanz, María Del Mar (2019-01)

Listar por autor "Lastra, Enrique"

A comprehensive custom panel evaluation for routine hereditary cancer testing: improving the yield of germline mutation detection ﻿

A PALB2 truncating mutation: Implication in cancer prevention and therapy of Hereditary Breast and Ovarian Cancer ﻿

Application of liquid biopsies in metastatic gastrointestinal cancer to identify candidate therapeutic targets ﻿

Evaluating the Effect of Unclassified Variants Identified in MMR Genes Using Phenotypic Features, Bioinformatics Prediction, and RNA Assays ﻿

Increased co-occurrence of pathogenic variants in hereditary breast and ovarian cancer and Lynch syndromes: A consequence of multigene panel genetic testing? ﻿

Multigene germline testing usefulness instead of BRCA1/2 single screening in triple negative breast cancer cases ﻿

Profiling of the genetic features of patients with breast, ovarian, colorectal and extracolonic cancers: Association to CHEK2 and PALB2 germline mutations ﻿

The highly prevalent BRCA2 mutation c.2808_2811del (3036delACAA) is located in a mutational hotspot and has multiple origins ﻿

Unraveling the molecular effect of a rare missense mutation in BRIP1 associated with inherited breast cancer ﻿

A comprehensive custom panel evaluation for routine hereditary cancer testing: improving the yield of germline mutation detection

A PALB2 truncating mutation: Implication in cancer prevention and therapy of Hereditary Breast and Ovarian Cancer

Application of liquid biopsies in metastatic gastrointestinal cancer to identify candidate therapeutic targets

Evaluating the Effect of Unclassified Variants Identified in MMR Genes Using Phenotypic Features, Bioinformatics Prediction, and RNA Assays

Increased co-occurrence of pathogenic variants in hereditary breast and ovarian cancer and Lynch syndromes: A consequence of multigene panel genetic testing?

Multigene germline testing usefulness instead of BRCA1/2 single screening in triple negative breast cancer cases

Profiling of the genetic features of patients with breast, ovarian, colorectal and extracolonic cancers: Association to CHEK2 and PALB2 germline mutations

The highly prevalent BRCA2 mutation c.2808_2811del (3036delACAA) is located in a mutational hotspot and has multiple origins

Unraveling the molecular effect of a rare missense mutation in BRIP1 associated with inherited breast cancer